These results reveal a critical link between mitochondrial dynamics and lipid metabolic reprogramming in ovarian cancer, with MIEF2‐mediated activation of the PI3K/AKT/mTOR/SREBP axis driving tumor aggressiveness. This evidence concerns the gene MTOR and neoplasm.